Literature DB >> 11447701

Infections in multiple myeloma.

F Paradisi1, G Corti, R Cinelli.   

Abstract

Multiple myeloma is a relatively rare but severe hematologic malignancy. Marked depression in production of normal immunoglobulins, mild neutropenia, and alkylant/steroid therapy or BMT/SCT all produce major suppression of the immune system in the totality of patients. Recurrent bacterial, fungal, and viral infections are an important cause of morbidity and the most common cause of death in these subjects. Prompt diagnosis and appropriate anti-infective chemotherapy are essential in order to reduce the risk of mortality.

Entities:  

Mesh:

Year:  2001        PMID: 11447701     DOI: 10.1016/s0891-5520(05)70151-3

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  6 in total

Review 1.  Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.

Authors:  D Atanackovic; T Luetkens; N Kröger
Journal:  Leukemia       Date:  2013-10-23       Impact factor: 11.528

Review 2.  Multiple myeloma presenting with pyomyositis caused by community-acquired methicillin-resistant Staphylococcus aureus: report of a case and literature review.

Authors:  Georgios Kalambokis; Areti Theodorou; Paraskevi Kosta; Epameinondas V Tsianos
Journal:  Int J Hematol       Date:  2008-05-21       Impact factor: 2.490

3.  Increased Length of Stay Associated With Antibiotic Use in Older Adults With Advanced Cancer Transitioned to Comfort Measures.

Authors:  Rupak Datta; Mojun Zhu; Ling Han; Heather Allore; Vincent Quagliarello; Manisha Juthani-Mehta
Journal:  Am J Hosp Palliat Care       Date:  2019-06-11       Impact factor: 2.500

4.  Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma.

Authors:  Taleb Azarm; Mojtaba Akbari; Arezo Azarm; Hamid Mohager
Journal:  J Res Med Sci       Date:  2012-01       Impact factor: 1.852

5.  Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.

Authors:  Jahangir Abdi; Tuna Mutis; Johan Garssen; Frank Redegeld
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

Review 6.  Epidemiology of infections in cancer patients.

Authors:  Teresa R Zembower
Journal:  Cancer Treat Res       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.